Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
The Lancet. Oncology
|
June 4, 2013
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T Seymour, Sarah R Brown, Gary Middleton, et al.
Translational Oncology
|
February 7, 2026
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer
Venkatesh Rajamanickam, Noah D Simons, Wesley Rosales, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
Somnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Gastroenterology
|
April 29, 2021
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Michael Eyres, Simone Lanfredini, Haonan Xu, et al.
The Journal of Pathology
|
June 23, 2025
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer
Joseph C Ward, Melissa Morgan, James Wood, et al.
Gut
|
December 24, 2025
Comparison between germline and somatic loss-of-function <i>RNF43</i> mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis
Claire Palles, Luke Freeman-Mills, Edward Arbe-Barnes, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Gut
|
September 30, 2019
Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification
Sam O Kleeman, Viktor H Koelzer, Helen Js Jones, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
Cell Stem Cell
|
August 5, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia
Ester Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
The Lancet. Oncology
|
June 4, 2013
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T Seymour, Sarah R Brown, Gary Middleton, et al.
Translational Oncology
|
February 7, 2026
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer
Venkatesh Rajamanickam, Noah D Simons, Wesley Rosales, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
Somnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Gastroenterology
|
April 29, 2021
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Michael Eyres, Simone Lanfredini, Haonan Xu, et al.
The Journal of Pathology
|
June 23, 2025
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer
Joseph C Ward, Melissa Morgan, James Wood, et al.
Gut
|
December 24, 2025
Comparison between germline and somatic loss-of-function <i>RNF43</i> mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis
Claire Palles, Luke Freeman-Mills, Edward Arbe-Barnes, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Gut
|
September 30, 2019
Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification
Sam O Kleeman, Viktor H Koelzer, Helen Js Jones, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
Cell Stem Cell
|
August 5, 2022
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia
Ester Gil Vasquez, Nadia Nasreddin, Gabriel N Valbuena, et al.
Page
of 3